Sionna Therapeutics Inc’s recent filing unveils that its 10% Owner TPG GP A, LLC acquired Company’s shares for reported $20.25 million on Feb 10 ’25. In the deal valued at $18.00 per share,1,125,000 shares were bought. As a result of this transaction, TPG GP A, LLC now holds 6,684,962 shares worth roughly $91.52 million.
Then, RA CAPITAL MANAGEMENT, L.P. bought 1,125,000 shares, generating $20,250,000 in total proceeds. Upon buying the shares at $18.00, the Director now owns 6,923,365 shares.
Before that, ORBIMED ADVISORS LLC bought 550,000 shares. Sionna Therapeutics Inc shares valued at $9,900,000 were divested by the Director at a price of $18.00 per share. As a result of the transaction, ORBIMED ADVISORS LLC now holds 3,704,959 shares, worth roughly $50.72 million.
TD Cowen initiated its Sionna Therapeutics Inc [SION] rating to a Buy in a research note published recently. A number of analysts have revised their coverage, including Stifel’s analysts, who began to cover the stock in early March with a ‘”a Buy”‘ rating. Guggenheim began covering SION with “Buy” recommendation on March 04, 2025.
Price Performance Review of SION
On Friday, Sionna Therapeutics Inc [NASDAQ:SION] saw its stock fall -1.37% to $13.69. Over the last five days, the stock has lost -8.61%. Sionna Therapeutics Inc shares have fallen nearly -45.24% since the year began.
Levels Of Support And Resistance For SION Stock
The 24-hour chart illustrates a support level at 12.41, which if violated will result in even more drops to 11.13. On the upside, there is a resistance level at 14.51. A further resistance level may holdings at 15.34. The Relative Strength Index (RSI) on the 14-day chart is 27.17, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.48, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 70.31%. Stochastics %K at 18.61% indicates the stock is a buying.
